EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA

Zouher Amzil iD, Amélie Derrien iD, Korian Lhaute, Aouregan Terre Terrillon iD, Simon Tanniou

Marine Drugs · 03.02.2026 · 24 (2) · 67

DOI: 10.3390/md24020067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 03.02.2026. Verfasst von Zouher Amzil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ifremer (French Research Institute for Exploitation of the Sea)/PHYTOX/METALG, F-44311 Nantes, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Directorate for Food of the Ministry of Agriculture and Food, General Directorate for Food of the Ministry of Agriculture and Food.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In France, as part of the monitoring program for the emergence of marine toxins in shellfish (EMERGTOX), brevetoxins (BTX-2, BTX-3) were first detected in shellfish from Corsica (Mediterranean Sea) in 2018. The complex metabolic transformation of brevetoxins in shellfish, coupled with the limited availability of analytical standards for most metabolites, complicates the accurate evaluation of contamination levels. To address this challenge, two complementary analytical approaches were implemented to quantify brevetoxin metabolites in shellfish samples collected from 2018 to 2023: (i) a targeted LC-MS/MS method specially developed for brevetoxins; and (ii) an ELISA capable of detecting metabolites for which no reference standards are available. Of the 11 brevetoxin metabolites targeted, 4 were quantified by LC-MS/MS: BTX-2, BTX-3, BTX-B5, and S-deoxy-BTX-B2 (including its isomers). The ELISA consistently detected brevetoxins in all Corsican samples previously confirmed positive by LC-MS/MS, with concentrations systematically exceeding those measured by LC-MS/MS. This overestimation may result from antibody cross-reactivity and from the presence of unidentified brevetoxin metabolites not detected by LC-MS/MS. Regardless of the analytical method used, the highest concentration detected exceeded the current French guideline value for brevetoxins in shellfish. To ensure consumer protection, a two-step monitoring strategy is proposed: initial screening via ELISA to estimate brevetoxin contamination, followed by confirmatory LC-MS/MS analysis to identify and quantify the specific metabolites.

Schlagwörter

Stichwörter der Autor:innen

ELISA KitLC-MS/MSbrevetoxinsmollusks

Autor:innen und Institutionen

  • Ifremer (French Research Institute for Exploitation of the Sea)/PHYTOX/METALG, F-44311 Nantes, France.
  • Ifremer (French Research Institute for Exploitation of the Sea)/COAST/LER-BO, F-29900 Concarneau, France.

ORCID-Profile: Zouher Amzil, Amélie Derrien, Aouregan Terre Terrillon

Förderung

  • Directorate for Food of the Ministry of Agriculture and Food
  • General Directorate for Food of the Ministry of Agriculture and Food

Zitieren

APA

Amzil, Z., Derrien, A., Lhaute, K., Terrillon, A. T., & Tanniou, S. (2026). Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA. Marine Drugs, 24(2), 67. https://doi.org/10.3390/md24020067

Vancouver

Amzil Z, Derrien A, Lhaute K, Terrillon AT, Tanniou S. Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA. Marine Drugs. 2026;24(2):67. doi:10.3390/md24020067

BibTeX
@article{Amzil2026,
  author = {Amzil, Zouher and Derrien, Amélie and Lhaute, Korian and Terrillon, Aouregan Terre and Tanniou, Simon},
  title = {Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {67},
  doi = {10.3390/md24020067}
}
Kostenlos starten →